The Actinobacillus pleuropneumoniae apxIV operon encodes an antibacterial toxin-immunity pair
Language English Country Germany Media print-electronic
Document type Journal Article
PubMed
39740637
DOI
10.1016/j.micres.2024.128043
PII: S0944-5013(24)00444-0
Knihovny.cz E-resources
- Keywords
- Actinobacillus pleuropneumoniae, Bacterial, Infectious Diseases, Pathogenesis, RTX proteins, Structural biology, Toxin-antitoxin system,
- MeSH
- Actinobacillus pleuropneumoniae * genetics pathogenicity immunology metabolism MeSH
- Anti-Bacterial Agents pharmacology MeSH
- Bacterial Proteins * genetics chemistry metabolism immunology MeSH
- Bacterial Toxins * genetics chemistry metabolism immunology MeSH
- Bacteriocins genetics MeSH
- Virulence Factors genetics metabolism MeSH
- Actinobacillus Infections microbiology veterinary MeSH
- Operon * MeSH
- Swine MeSH
- Virulence MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Anti-Bacterial Agents MeSH
- ApxIVA protein, Actinobacillus pleuropneumoniae MeSH Browser
- Bacterial Proteins * MeSH
- Bacterial Toxins * MeSH
- Bacteriocins MeSH
- Virulence Factors MeSH
The ApxIVA protein belongs to a distinct class of a "clip and link" activity of Repeat-in-ToXin (RTX) exoproteins. Along with the three other pore-forming RTX toxins (ApxI, ApxII and ApxIII), ApxIVA serves as a major virulence factor of Actinobacillus pleuropneumoniae, the causative agent of porcine pneumonia. The gene encoding ApxIVA is located on a bicistronic operon downstream of the orf1 gene and is expressed exclusively under in vivo conditions. Both ApxIVA and ORF1 are essential for full virulence of A. pleuropneumoniae, but the molecular mechanisms by which they contribute to the pathogenicity are not yet understood. Here, we provide a comprehensive structural and functional analysis of ApxIVA and ORF1 proteins. Our findings reveal that the N-terminal segment of ApxIVA shares structural similarity with colicin M (ColM)-like bacteriocins and exhibits an antimicrobial activity. The ORF1 protein resembles the colicin M immunity protein (Cmi) and, like Cmi, is exported to the periplasm through its N-terminal signal peptide. Additionally, ORF1 can protect bacterial cells from the antimicrobial activity of ApxIVA, suggesting that ORF1 and ApxIVA function as an antibacterial toxin-immunity pair. Moreover, we demonstrate that fetal bovine serum could elicit ApxIVA and ORF1 production under in vitro conditions. These findings highlight the coordinated action of various RTX determinants, where the fine-tuned spatiotemporal production of ApxIVA may enhance the fitness of A. pleuropneumoniae, facilitating its invasion to a resident microbial community on the surface of airway mucosa.
References provided by Crossref.org